​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

​​

Section1

​Announcements

  • Upcoming: Prescription Drug Affordability Board Stakeholder Council (PDASC) Meeting- June 23, 2025 at 2:00PM. Please visit the Stakeholder Council page​ for more information and registration information.
  • Cost Review Study Process- Request for Information begins​ May 28th, 2025 for Dupixent​ and Skyrizi. Please visit the RFI page for more information concerning submissions and technical assistance. 
  • Join the PDAB Mailing List here​.

Section2

​Diligent Subscription IFB

Solicitation #  BPM051033​
Title: Diligent Subscription IFB
Issue Date: 5/05/2025
Closing Date: 6/4/2025 at 11:00AM
Diligent Subscription IFB
Pre-Bid Conference Response Form



Section3

Section5